Benefits and harms of prostate-specific cancer screening: an evidence update for the U.S. Preventive Services Task Force
Lin K, Lipsitz R, Miller T, Janakiraman S
Record ID 32011000581
English
Authors' objectives:
To examine new evidence of benefits and harms of screening asymptomatic men for prostate cancer with PSA testing.
Authors' recommendations:
Prostate-specific antigen screening is associated with psychological harms, and its potential benefits remain uncertain.
Details
Project Status:
Completed
URL for project:
http://www.ncbi.nlm.nih.gov/books/NBK43401/
Year Published:
2008
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Adult
- Aged
- Male
- Middle Aged
- Risk Assessment
- Biopsy
- Mass Screening
- Physical Examination
- Prostate-Specific Antigen
- Prostatic Neoplasms
- Research Design
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.